First 23-Patient Safety and Efficacy Data from Nexicart-2, the First U.S. Trial of CAR-T in R/R Light Chain (AL) Amyloidosis, Nxc-201

Transplantation and Cellular Therapy 2026

View at publisher
Authors: Heather J. Landau, Shahzad Raza, Aaron Rosenberg, Jeffrey A. Zonder, Raymond Comenzo, Vaishali Sanchorawala, Michaela Liedtke, Amandeep Godara, Jonathan L. Kaufman, Michael Alan Rosenzweig, Charlotte Hughes, Eugène Brailovski
+7 more Hamza Hashmi, Mehrdad Abedi, Sham Mailankody, Jae H Park, David Marks, Sridevi Rajeeve, Jennifer Liu
DOI: 10.1016/j.jtct.2025.12.018
Cited by: 1

Fields of Study & Subjects

Amyloidosis: Diagnosis Treatment Outcomes Occupational and environmental lung diseases Sarcoidosis and Beryllium Toxicity Research

Publication details

Journal / source
Transplantation and Cellular Therapy
Publisher
Elsevier BV
Volume
32
Issue
2
Pages
S4–S4
Publication date
1 February 2026
Language
EN